Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants

doi:10.1084/jem.177.4.1021

This Article

	Full Text (PDF, 1358K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Kittlesen, D. J.
	Articles by Braciale, T. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Kittlesen, D. J.
	Articles by Braciale, T. J.


Social Bookmarking

	What's this?

ARTICLES

Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants

DJ Kittlesen, LR Brown, VL Braciale, JP Sambrook, MJ Gething and TJ Braciale
Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville 22908.

Human lymphoblastoid cells transiently expressing the hemagglutinin (HA) glycoprotein of influenza virus are rapidly and efficiently recognized by CD4+ HA-specific T lymphocytes. This endogenous presentation pathway is sensitive to chloroquine and is therefore likely related to the classical class II major histocompatibility complex (MHC) exogenous pathway of antigen presentation. In this study we have examined a series of transport-defective HA mutants. We correlate the intracellular fate of the native antigen with its presentation characteristics. We have found that the native antigen must enter the secretory pathway since a cytosolic form is not presented. However, surface expression and normal trafficking through the Golgi apparatus are not required for efficient presentation. Instead, escape of native antigen from the endoplasmic reticulum appears to be both necessary and sufficient for gaining access to a compartment where antigen is processed and binds class II MHC molecules.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Heller, K. N., Gurer, C., Munz, C. (2006). Virus-specific CD4+ T cells: ready for direct attack. JEM 203: 805-808 [Abstract] [Full Text]
Dissanayake, S. K., Tuera, N., Ostrand-Rosenberg, S. (2005). Presentation of Endogenously Synthesized MHC Class II-Restricted Epitopes by MHC Class II Cancer Vaccines Is Independent of Transporter Associated with Ag Processing and the Proteasome. J. Immunol. 174: 1811-1819 [Abstract] [Full Text]
Vaz-Santiago, J., Lule, J., Rohrlich, P., Jacquier, C., Gibert, N., Le Roy, E., Betbeder, D., Davignon, J.-L., Davrinche, C. (2001). Ex Vivo Stimulation and Expansion of both CD4+ and CD8+ T Cells from Peripheral Blood Mononuclear Cells of Human Cytomegalovirus-Seropositive Blood Donors by Using a Soluble Recombinant Chimeric Protein, IE1-pp65. J. Virol. 75: 7840-7847 [Abstract] [Full Text]
Le Roy, E., Mühlethaler-Mottet, A., Davrinche, C., Mach, B., Davignon, J.-L. (1999). Escape of Human Cytomegalovirus from HLA-DR-Restricted CD4+ T-Cell Response Is Mediated by Repression of Gamma Interferon-Induced Class II Transactivator Expression. J. Virol. 73: 6582-6589 [Abstract] [Full Text]
Aichinger, G., Karlsson, L., Jackson, M. R., Vestberg, M., Vaughan, J. H., Teyton, L., Lechler, R. I., Peterson, P. A. (1997). Major Histocompatibility Complex Class II-dependent Unfolding, Transport, and Degradation of Endogenous Proteins. J. Biol. Chem. 272: 29127-29136 [Abstract] [Full Text]
Gueguen, M., Long, E.�O. (1996). Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the�antigen. Proc. Natl. Acad. Sci. USA 93: 14692-14697 [Abstract] [Full Text]